Analysts tweak 12-month target prices on Fisher & Paykel Healthcare

Analysts tweak 12-month target prices on Fisher & Paykel Healthcare
(Image: Fisher & Paykel Healthcare)
Rebecca Howard
Analysts rejigged their 12-month target prices on Fisher & Paykel Healthcare after it lifted its full-year guidance but retained fairly downbeat ratings. Last Friday, the healthcare products manufacturer lifted its full-year revenue guidance to $1.73 billion, from $1.7b, and net profit to $260 million-$265m, from $250m-$260m.Forsyth Barr analysts lifted their target price to $23.45 from $22.95. The shares last traded at $26.62.They noted that F&P Healthcare referenced stronger hospital consumables revenue and “homecare r...

More Markets

Tiwai Point power deal buoys NZ sharemarket, up 2.68%
Markets Market close

Tiwai Point power deal buoys NZ sharemarket, up 2.68%

Long-awaited 20-year deal drives market to highest single-day rise in years. 

Graham Skellern 31 May 2024
South Port welcomes smelter news
Infrastructure

South Port welcomes smelter news

Trade from the smelter contributes around $2m to its NPat result, port says.

Staff reporters 31 May 2024
Smelter deal brings certainty and higher share prices
Markets

Smelter deal brings certainty and higher share prices

It will mean new electricity generation will be built quicker.

Ian Llewellyn 31 May 2024
Update: Tiwai Point's future secured
Markets

Update: Tiwai Point's future secured

The smelter has signed 20-year electricity arrangements with three energy companies.

John Anthony 31 May 2024